299
Participants
Start Date
June 30, 2020
Primary Completion Date
July 2, 2024
Study Completion Date
June 30, 2026
Acupuncture
Acupuncture treatments will be scheduled to cover the period of high symptom burden. Acupuncture will start on Day 0 and continue once daily to Day 15, as long as the patient is inpatient or comes to the clinic for post-transplantation follow-up. Electrical stimulation (e-acupuncture) may be applied to the ST36 and SP6 points when appropriate as per standard acupuncture practice.
opioid
All study patients will receive the usual HSCT care and pain management regimens (usually opioids) as per standard practice at the study institution.
Assessments
Participants will be asked to complete patient reported outcomes assessments online using REDCap or, If they prefer, via pencil and paper or over the phone. Assessments at baseline (within 4 weeks before HiChemo) and on or about days 7, 15, 30, and 90 after the first dose of HiChemo.
Memorial Sloan Kettering Cancer Center, New York
Fred Hutchinson Cancer Research Center, Seattle
Seattle Cancel Care Alliance (Data Collection Only), Seattle
Patient-Centered Outcomes Research Institute
OTHER
Hackensack Meridian Health
OTHER
Memorial Sloan Kettering Cancer Center
OTHER